Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency. [electronic resource]
Producer: 20160719ISSN:- 1757-790X
- Adult
- Antimanic Agents -- administration & dosage
- Brain Diseases -- chemically induced
- Cardiomyopathies -- chemically induced
- Carnitine -- blood
- Female
- Humans
- Hyperammonemia -- chemically induced
- Muscle Weakness -- chemically induced
- Muscular Diseases -- chemically induced
- Psychotic Disorders -- drug therapy
- Treatment Outcome
- Valproic Acid -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.